Antifungal — Tinea Capitis
Pregnancy: CONTRAINDICATED — teratogenic; must use effective contraception during and for 1 month after treatment
Griseofulvin
Brand names: Grisovin
Adult dose
Dose: 500 mg once daily (or 250 mg twice daily) for 6–8 weeks (tinea capitis); up to 1 g/day for severe infections
Route: Oral (take with fatty meal — enhanced absorption)
Frequency: Once or twice daily
Max: 1 g/day
Systemic antifungal for tinea capitis (scalp ringworm) — particularly effective for Microsporum canis infections where terbinafine is less effective. Also used for tinea corporis, tinea pedis, and onychomycosis when other agents fail or are contraindicated.
Paediatric dose
Dose: 10 mg/kg/day (or 10–20 mg/kg/day for fine-particle preparation) mg/kg
Route: Oral (with fatty food or full-fat milk)
Frequency: Once or twice daily
Max: 500 mg/day
BNFc: tinea capitis — 10 mg/kg once daily for 6–12 weeks; Microsporum canis may require longer (12–16 weeks). Suspension not licensed — tablets can be crushed and given with fatty food.
Dose adjustments
Renal
No dose adjustment required
Hepatic
Avoid in significant hepatic impairment
Paediatric weight-based calculator
BNFc: tinea capitis — 10 mg/kg once daily for 6–12 weeks; Microsporum canis may require longer (12–16 weeks). Suspension not licensed — tablets can be crushed and given with fatty food.
Clinical pearls
- First-line for Microsporum canis tinea capitis — terbinafine has inferior efficacy against Microsporum species; species identification (culture + PCR) guides treatment choice
- Trichophyton species (T. tonsurans, T. violaceum): terbinafine preferred; Microsporum species: griseofulvin preferred
- Must be taken with fatty food — lipophilic drug requiring fat for absorption; full-fat milk is ideal vehicle for children
- Contraception: OCP efficacy reduced — additional barrier contraception required; pregnancy must be excluded before initiating and for 1 month after
- School exclusion in tinea capitis: UK guidance (PHE/BAD) — children do NOT need to be excluded from school; can return once treatment started; share shampoo and combs are main transmission vectors
- Selenium sulfide or ketoconazole shampoo: adjunct to systemic treatment — reduces contagion by killing surface spores
Contraindications
- Pregnancy — CONTRAINDICATED and for 1 month after stopping (teratogenic)
- Severe hepatic impairment
- Porphyria (precipitates acute attack)
- Systemic lupus erythematosus (may exacerbate)
- Hypersensitivity to griseofulvin
Side effects
- Headache (most common)
- GI disturbance
- Photosensitivity
- Skin rash (including SJS/TEN rare)
- Hepatotoxicity
- Leucopenia (prolonged use)
- Peripheral neuropathy (prolonged use)
- Lupus-like reactions
Interactions
- Warfarin — reduces anticoagulant effect (induces CYP enzymes; monitor INR)
- OCP — reduces efficacy (enzyme induction; additional contraception required)
- Ciclosporin — reduces ciclosporin levels
- Alcohol — flushing reaction
Monitoring
- FBC and LFTs (baseline; monthly for prolonged courses)
- Treatment response (scale/hair loss improvement at 4–6 weeks)
- Mycological cure (post-treatment culture)
Reference: BNFc; BNF 90; BNFc; BAD Tinea Capitis Guidelines 2014; PHE Guidance on Tinea Capitis in Schools; NICE CKS Ringworm. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD